glp-1 obesity drug news today sep 30 2025 Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom The outlook for obesity from

Learn how the new Wegovy pill compares to injections and what this means for your weight loss care.

Tirzepatide was more efficacious in reducing body weight

| 10 comments on LinkedIn

Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease burden in China

The triagonist-induced increase in GSIS was unchanged in the absence of either Gipr or Gcgr

Individualization is Key: The ADA strongly advocates tailoring HbA1c goals based on: Duration of diabetes Risk of hypoglycemia Life expectancy Comorbidities (cardiovascular disease, CKD) Patient preference and treatment burden Beyond HbA1c: Modern diabetes care increasingly integrates Continuous Glucose Monitoring (CGM) metrics such as Time in Range (TIR) alongside HbA1c